{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T20:33:05Z","timestamp":1792873985125,"version":"4.5.0"},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2016,8,2]],"date-time":"2016-08-02T00:00:00Z","timestamp":1470096000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0004902","type":"journal-article","created":{"date-parts":[[2016,8,2]],"date-time":"2016-08-02T17:28:05Z","timestamp":1470158885000},"page":"e0004902","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":36,"title":["Post-exposure Treatment with Anti-rabies VHH and Vaccine Significantly Improves Protection of Mice from Lethal Rabies Infection"],"prefix":"10.1371","volume":"10","author":[{"given":"Sanne","family":"Terryn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Francart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Rommelaere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catelijne","family":"Stortelers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Van Gucht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,8,2]]},"reference":[{"issue":"6","key":"ref1","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1473-3099(02)00287-6","article-title":"Rabies re-examined","volume":"2","author":"CE Rupprecht","year":"2002","journal-title":"The Lancet Infectious Diseases"},{"issue":"5","key":"ref2","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2217\/17460794.3.5.481","article-title":"Concepts in the pathogenesis of rabies","volume":"3","author":"B Dietzschold","year":"2008","journal-title":"Future Virol"},{"issue":"2","key":"ref3","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1474-4422(02)00041-8","article-title":"Human rabies: a disease of complex neuropathogenetic mechanisms and diagnostic challenges","volume":"1","author":"T Hemachudha","year":"2002","journal-title":"The Lancet Neurology"},{"issue":"5","key":"ref4","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/(SICI)1097-4598(200005)23:5<720::AID-MUS9>3.0.CO;2-5","article-title":"Rabies virus entry at the neuromuscular junction in nerve-muscle cocultures","volume":"23","author":"P Lewis","year":"2000","journal-title":"Muscle Nerve"},{"issue":"4","key":"ref5","doi-asserted-by":"crossref","first-page":"e0003709","DOI":"10.1371\/journal.pntd.0003709","article-title":"Estimating the Global Burden of Endemic Canine Rabies","volume":"9","author":"K Hampson","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"ref6","unstructured":"World Health Organisation. Rabies vaccines WHO position paper. 2007 Dec 14. Report No.: 49\/50."},{"issue":"4","key":"ref7","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1086\/324628","article-title":"Postexposure Treatment of Rabies Infection: Can It Be Done without Immunoglobulin?","volume":"34","author":"H Wilde","year":"2002","journal-title":"Clinical Infectious Diseases"},{"issue":"4","key":"ref8","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2310\/7060.2000.00057","article-title":"Neutralizing Antibodies to Rabies Following Injection of Rabies Immune Globulin into Gluteal Fat or Deltoid Muscle","volume":"7","author":"P Chomchay","year":"2000","journal-title":"Journal of Travel Medicine"},{"issue":"5","key":"ref9","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S1473-3099(11)70340-1","article-title":"Passive immunity in the prevention of rabies","volume":"12","author":"L Both","year":"2012","journal-title":"The Lancet Infectious Diseases"},{"issue":"4","key":"ref10","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1006\/biol.1998.0156","article-title":"Immunogenicity and Safety in Adults of a New Chromatographically Purified Vero-cell Rabies Vaccine (CPRV): a Randomized, Double-blind Trial with Purified Vero-cell Rabies Vaccine (PVRV)","volume":"26","author":"J Lang","year":"1998","journal-title":"Biologicals"},{"key":"ref11","article-title":"WHO Consultation on a Rabies Monoclonal Antibody Cocktail for Rabies Post Exposure Treatment","year":"2002"},{"issue":"5","key":"ref12","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.coph.2008.07.006","article-title":"Single-domain antibodies as building blocks for novel therapeutics","volume":"8","author":"D Saerens","year":"2008","journal-title":"Current Opinion in Pharmacology"},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00253-007-1142-2","article-title":"Properties, production, and applications of camelid single-domain antibody fragments","volume":"77","author":"MM Harmsen","year":"2007","journal-title":"Appl Microbiol Biotechnol"},{"issue":"3","key":"ref14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00430-009-0116-7","article-title":"Single domain antibodies: promising experimental and therapeutic tools in infection and immunity","volume":"198","author":"J Wesolowski","year":"2009","journal-title":"Medical Microbiology and Immunology"},{"issue":"10","key":"ref15","doi-asserted-by":"crossref","first-page":"e109367","DOI":"10.1371\/journal.pone.0109367","article-title":"Protective Effect of Different Anti-Rabies Virus VHH Constructs against Rabies Disease in Mice","volume":"9","author":"S Terryn","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jviromet.2011.01.019","article-title":"A non-invasive intranasal inoculation technique using isoflurane anesthesia to infect the brain of mice with rabies virus","volume":"173","author":"V Rosseels","year":"2011","journal-title":"J Virol Methods"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/0042-6822(91)90145-2","article-title":"Spread of the CVS strain of rabies virus and of the avirulent mutant AvO1 along the olfactory pathways of the mouse after intranasal inoculation","volume":"183","author":"F Lafay","year":"1991","journal-title":"Virology"},{"issue":"1G\u00c7\u00f42","key":"ref18","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jviromet.2013.03.020","article-title":"Evaluation of a non-invasive, inhalational challenge method for rabies vaccine potency assay","volume":"190","author":"CE Lewis","year":"2013","journal-title":"Journal of Virological Methods"},{"issue":"4","key":"ref19","doi-asserted-by":"crossref","first-page":"e17665","DOI":"10.1371\/journal.pone.0017665","article-title":"Llama-derived single domain antibodies to build multivalent, superpotent and broadened neutralizing anti-viral molecules","volume":"6","author":"A Hultberg","year":"2011","journal-title":"PLoS One"},{"issue":"8","key":"ref20","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/infdis\/jiq168","article-title":"Nanobodies with in vitro neutralizing activity protect mice against H5N1 influenza virus infection","volume":"203","author":"LI Iba\u00f1ez","year":"2011","journal-title":"J Infect Dis"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1086\/375247","article-title":"Development of a Cocktail of Recombinant-Expressed Human Rabies Virus-Neutralizing Monoclonal Antibodies for Postexposure Prophylaxis of Rabies","volume":"188","author":"M Prosniak","year":"2003","journal-title":"Journal of Infectious Diseases"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"256175","DOI":"10.1155\/2014\/256175","article-title":"A two-step lyssavirus real-time polymerase chain reaction using degenerate primers with superior sensitivity to the fluorescent antigen test","volume":"2014","author":"V Suin","year":"2014","journal-title":"Biomed Res Int"},{"key":"ref23","first-page":"407","article-title":"Effects of Homologous or Heterologous Antiserum on Neutralizing-Antibody Response to Rabies Vaccine","volume":"39","author":"BG Archer","year":"1968","journal-title":"Bull Wld Hlth Org"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ijid.2005.10.007","article-title":"Assessing the burden of human rabies in India: results of a national multi-center epidemiological survey","volume":"11","author":"MK Sudarshan","year":"2007","journal-title":"International Journal of Infectious Diseases"},{"issue":"5","key":"ref25","first-page":"360","article-title":"Re-evaluating the burden of rabies in Africa and Asia","volume":"83","author":"DL Knobel","year":"2005","journal-title":"Bull World Health Organ"},{"issue":"13","key":"ref26","doi-asserted-by":"crossref","DOI":"10.2807\/ese.14.13.19166-en","article-title":"Is there a need for anti-rabies vaccine and immunoglobulins rationing in Europe?","volume":"14","author":"H Bourhy","year":"2009","journal-title":"Euro Surveill"},{"issue":"7","key":"ref27","doi-asserted-by":"crossref","first-page":"e495","DOI":"10.1016\/j.ijid.2011.03.023","article-title":"Clinical and epidemiological features of human rabies cases in the Philippines: a review from 1987 to 2006","volume":"15","author":"EM Dimaano","year":"2011","journal-title":"Int J Infect Dis"},{"issue":"44","key":"ref28","doi-asserted-by":"crossref","first-page":"7605","DOI":"10.1016\/j.vaccine.2007.08.054","article-title":"Failures of post-exposure rabies prophylaxis","volume":"25","author":"H Wilde","year":"2007","journal-title":"Vaccine"},{"key":"ref29","article-title":"Rabies encephalitis in a child: a failure of rabies post exposure prophylaxis?","author":"F Tinsa","year":"2015","journal-title":"BMJ Case Reports"},{"issue":"1","key":"ref30","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1086\/649873","article-title":"Failure of Rabies Postexposure Prophylaxis In Patients Presenting with Unusual Manifestations","volume":"50","author":"P Shantavasinkul","year":"2010","journal-title":"Clinical Infectious Diseases"},{"issue":"2","key":"ref31","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0264-410X(03)00559-0","article-title":"Efficacy of rabies immunoglobulins in an experimental post-exposure prophylaxis rodent model","volume":"22","author":"A Servat","year":"2003","journal-title":"Vaccine"},{"issue":"1","key":"ref32","first-page":"33","article-title":"Humoral and cell-mediated immune responses to various economical regimens of purified Vero cell rabies vaccine","volume":"5","author":"P Phanuphak","year":"1987","journal-title":"Asian Pac J Allergy Immunol"},{"key":"ref33","first-page":"747","article-title":"Inhibitory Effect of Passive Antibody on Active Immunity Induced Against Rabies by Vaccination","volume":"45","author":"TJ Wiktor","year":"1971","journal-title":"Bull Wld Hlth Org"},{"issue":"11","key":"ref34","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/0264-410X(92)90510-Q","article-title":"Inhibition of immune responses against rabies virus by monoclonal antibodies directed against rabies virus antigens","volume":"10","author":"CL Schumacher","year":"1992","journal-title":"Vaccine"},{"issue":"4","key":"ref35","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.coi.2008.06.005","article-title":"Antibodies against viruses: passive and active immunization","volume":"20","author":"M Law","year":"2008","journal-title":"Current Opinion in Immunology"},{"key":"ref36","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2014.00446","article-title":"Maternal antibodies: clinical significance, mechanism of interference with immune responses, and possible vaccination strategies","volume":"5","author":"S Niewiesk","year":"2014","journal-title":"Frontiers in Immunology"},{"issue":"12","key":"ref37","doi-asserted-by":"crossref","first-page":"5526","DOI":"10.1016\/j.bbagen.2013.04.023","article-title":"Albumin as a versatile platform for drug half-life extension","volume":"1830","author":"D Sleep","year":"2013","journal-title":"Biochimica et Biophysica Acta (BBA)\u2014General Subjects"},{"issue":"3","key":"ref38","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1017\/S0950268800066619","article-title":"Purified chick embryo cell rabies vaccine: economical multisite intradermal regimen for post-exposure prophylaxis","volume":"99","author":"P Suntharasamai","year":"1987","journal-title":"Epidemiol Infect"},{"issue":"3","key":"ref39","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1017\/S0022172400066286","article-title":"Purified Vero cell rabies vaccine and human diploid cell strain vaccine: comparison of neutralizing antibody responses to post-exposure regimens","volume":"96","author":"P Suntharasamai","year":"1986","journal-title":"J Hyg (Lond)"},{"issue":"10","key":"ref40","doi-asserted-by":"crossref","first-page":"e535","DOI":"10.1371\/journal.pntd.0000535","article-title":"The production of antibody by invading B cells is required for the clearance of rabies virus from the central nervous system","volume":"3","author":"DC Hooper","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"ref41","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/ni1328","article-title":"See no evil, hear no evil, do no evil: the lessons of immune privilege","volume":"7","author":"JY Niederkorn","year":"2006","journal-title":"Nat Immunol"},{"issue":"1","key":"ref42","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1128\/IAI.18.1.220-225.1977","article-title":"Role of host immune response in the development of either encephalitic or paralytic disease after experimental rabies infection in mice","volume":"18","author":"Y Iwasaki","year":"1977","journal-title":"Infect Immun"},{"issue":"5","key":"ref43","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S1474-4422(13)70038-3","article-title":"Human rabies: neuropathogenesis, diagnosis, and management","volume":"12","author":"T Hemachudha","year":"2013","journal-title":"Lancet Neurol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1746-6148-9-31","article-title":"Reduced viral burden in paralytic compared to furious canine rabies is associated with prominent inflammation at the brainstem level","volume":"9","author":"S Shuangshoti","year":"2013","journal-title":"BMC Vet Res"},{"issue":"6","key":"ref45","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.copbio.2011.06.012","article-title":"Strategies for extended serum half-life of protein therapeutics","volume":"22","author":"RE Kontermann","year":"2011","journal-title":"Current Opinion in Biotechnology"}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0004902","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T19:15:14Z","timestamp":1656962114000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0004902"}},"subtitle":[],"editor":[{"given":"Charles E","family":"Rupprecht","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,8,2]]},"references-count":45,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2016,8,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0004902","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,2]]}}}